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How this Fits in  
What is already known 
Trigger tools have been used to identify patient safety events in UK primary care since 2009. 
Their use has been mainly limited to the measurement of the rate of adverse events. They 
are not widely used in primary care settings.  
What this study adds 
Falling eGFR trigger tools based on results in the electronic health record can be easily 
incorporated into the regular work of general practice. Interview and reflective data 
illustrated that practice use of the trigger tool supported the patient safety agenda and in 
addition encouraged team and individual learning about CKD management.  
  
Abstract 
Background 
An innovative programme to improve identification and management of chronic kidney 
disease (CKD) in primary care was implemented across three clinical commissioning groups 
(CCGs) in 2016.  This included a falling estimated glomerular filtration rate (eGFR) trigger 
tool built from data within the electronic health record (EHR). This patient safety tool 
notifies GP practices when falling eGFR values are identified. By alerting clinicians to 
patients with possible CKD progression the tool invites clinical review, the option for 
specialist advice, and written reflection on management.  
 
Aim  
To compare practitioner perceptions of trigger tool use and value from interview data, with 
the written reflections on clinical management recorded within the tools.  
 
Method 
Eight semi-structured interviews with 6 GPs, 1 pharmacist and 1 practice manager were 
recorded and transcribed. Thematic analysis of the interview transcripts was undertaken 
using framework analysis. The free-text reflective comments recorded in the trigger tools of 
1921 cases identified as having a fall in eGFR, were organised by referral category ‘yes’ and 
‘no’, with each category further stratified by age into ‘younger’ and ‘older’ cases. 
Subsequently the themes arising from the interviews were compared with the descriptive 
analysis of the reflective comments.  
 
Findings 
Three themes emerged from interviews: Getting started, Patient safety and Practitioner and 
Practice learning. Well organised practices found the tool was readily embedded into 
workflow and expressed greater motivation for using it. The trigger tool was seen to 
contribute to patient safety, and as a tool for learning about CKD management, both 
individually and as a practice. Reflective comments from 1921 trigger tools were examined, 
these supported the theme of patient safety from the interviews. However the free text 
data, stratified by age, challenged the expectation that younger cases would have higher 
referral rates, driven by a higher level of risk for CKD progression.  
Conclusion  
Building electronic trigger tools from the EHR can identify patients with a falling eGFR 
prompting review of the eGFR trajectory and management plan. Interview and reflective 
data illustrated that practice use of the trigger tool supported the patient safety agenda and 
in addition encouraged team and individual learning about CKD management. 
 
 
 
  
Make the right thing easy to do: using trigger tools for safety and learning in chronic 
kidney disease. 
 
Introduction 
The prevalence of Chronic Kidney Disease (CKD) stages 3-5 in the UK is estimated to be 5-
6%. (1, 2)  Early identification of people with CKD in primary care, particularly among those 
with risk factors such as diabetes and hypertension, enables proactive management of 
blood pressure, cardiovascular risk and lifestyle factors and referral to specialist services 
where there is evidence of progressive disease.(3)  
The UK national CKD audit in primary care  demonstrated that on average 70% of 
biochemically confirmed cases of CKD (stages 3-5) were given a diagnostic Read code. (1) 
There was wide variation between practices, with the proportion of CKD cases un-coded 
ranging between 0% to 80%.  Other studies have shown varying GP expertise in managing 
CKD. (4, 5) The second part of the national CKD audit linked hospital data on outcomes to 
the cases identified in primary care. There were associations between lack of coding in 
primary care with higher rates of unplanned hospital admissions, acute kidney injury 
admissions and deaths. (6)   
In 2016 three east London CCGs and the local renal unit developed an innovative 
community kidney service. This system wide change was conceived as a renal learning 
health system (7), in which data from all parts of the system are transformed into 
knowledge and used as feedback to improve both the system organisation and clinical 
performance within it. There are 136 practices within these CCGs, serving a population of 
850,000 patients. At the start of the project, practice diagnostic coding for CKD ranged from 
20%-80% reflecting the national average.  In addition, late referral of patients with 
progressive CKD to specialist end stage renal disease services, defined as those who needed 
renal replacement therapy within 3 months of being referred, was 39% compared to the 
national average of 16.1%.(8)  Previous quality initiatives (QI) in the three study CCGs  had 
used prevalence searches – to find and code cases and improve management by regular 
review, and dashboards to summarise comparative practice data. (9, 10) 
 
 
The community kidney service had four components:  
i) A package of IT tools which support practices to identify patients requiring diagnostic 
coding, improvements to blood pressure and cardiovascular management. Trigger 
tools, using pathology results from the electronic health record (EHR), are run 
monthly by practices and identify CKD cases with a falling eGFR. These trigger tool 
alerts are the focus of this paper. 
ii) Regular practice facilitation on clinical data management offered routinely by the 
Clinical Effectiveness Group (CEG) supported this package.(11) Additional renal 
specific clinical facilitation, which focussed on the importance of CKD coding, CVD 
and BP management, was offered to practices in the lowest decile of CKD coding. 
iii) A virtual CKD hospital clinic enabling nephrologists to see the full primary care EHR, 
with informed patient consent, and document advice in the shared record. The 
virtual clinic has a short wait time (approximately 7 days) and triages patients who 
require further investigation into nephrology out-patient clinics. Less than 20% of 
referrals require a traditional out-patient appointment. 
iv) An education programme for patients and practitioners. Continuing professional 
development sessions for GPs and practice nurses were delivered at CCG, cluster and 
practice level. Patient education sessions for those referred into the service were led 
by specialist renal nurses. These group and individual sessions, based in community 
facilities in each CCG, used conversation maps to provide information and encourage 
lifestyle changes to improve health. (12)  
 
Trigger tools 
Triggers are defined as easily identifiable flags, occurrences, or prompts in patient records 
that alert reviewers to potential adverse events that may otherwise be undetected.(13) 
Trigger tools, such as the IHI Global Trigger Tool for Measuring Adverse Events (14) are 
widely used in USA secondary care to estimate the prevalence of errors and harms. In UK 
primary care trigger tools have also been used to estimate the prevalence of patient safety 
events.(15) However, the time required for case note reviews, and the relatively low yield of 
events (around 9%) has limited uptake across general practice.  
Adapting the tool to identify patient safety events from focussed searches in the routine 
clinical data recorded in the EHR is more time efficient, produces a higher rate of potential 
errors, and is welcomed by GPs as a safety intervention that identifies patients who 
otherwise fall ‘under the radar of safety’.(13)  
 
Trigger tool for progressive CKD 
This quality improvement programme introduced the falling eGFR trigger tool. This patient 
safety tool provides a practice alert when a new eGFR value less than 60ml/min/1.73m2 is 
preceded by one with a value of 10ml greater. The rationale for introducing this tool is that 
identification of progressive CKD requires observation of eGFR over time. The tool 
encourages clinicians to undertake a notes review and examine the graph of eGFR 
trajectory. It provides a safety ‘backstop’ for busy clinicians viewing results, and invites 
reflection on whether clinical review or referral is indicated. The trigger tool is run monthly 
in participating practices.  Figure 1 shows the trigger tool practice interface.  
 
Figure 1. The falling eGFR trigger tool practice interface. The final column ‘Reflection on 
clinical management’, invites clinicians to enter free-text. 
 
 
 
 
Study aims 
To compare practitioner perceptions of trigger tool use and value from interview data, with 
the written reflections on clinical management recorded within the tools.  
 
Methods 
Eight semi-structured interviews with practice staff were carried out. Free-text data from 
the reflection column on 1921 completed trigger tools from all practices in two participating 
CCGs were collected and analysed. Using both data sets enabled us to compare the 
practitioner perceptions of the trigger tools (from the face-to-face interviews) with the 
actions of clinicians (based on the reflective comments).  
 
Interviews 
Practices known to the research team were contacted by the researchers to request 
participation in the study, providing a purposive sample. Interviews were conducted face-to-
face in the participant’s practice using the structure-process-outcome framework (16) as an 
interview guide. The interview questions are shown in Appendix 1. Interviews were digitally 
recorded with participants’ consent and transcribed verbatim.   
A framework analysis approach(17, 18) was adopted, whereby a descriptive or conceptual 
label is assigned to excerpts of raw data (coding). Two members of the research team 
independently coded the text to ensure trustworthiness of the data, (18) then worked 
together to group the codes into clearly defined categories, which subsequently became the 
analytic framework. (17)  
 
Reflection data 
Reflective comments over a 2-year period (Jan 2016 -Dec 2017) were extracted from the 
trigger tools. Comments were categorised by age of the patient as ‘Younger’ (aged ≤60 
years) and ‘Older’ (aged ≥80 years), based on existing preconceptions about the data.  These 
age bands were chosen because progressive CKD in younger people may have more serious 
outcomes, and may be less well recognised in primary care. (19)   
A qualitative description (QD) approach to analysis was adopted. This allows for low 
inference descriptions of the data which was suitable for reflective comments which were 
often very brief. (20, 21)   
The QD method included an iterative process of reading the comments to identify themes, 
until a saturation point was reached. There was generally one theme per entry, and 
sometimes a theme was not ascribed due to the comment’s briefness. (see Appendix 2 for 
examples of reflective data) This analysis lends itself to Sandelowski’s approach to QD, (22) 
in that arrangement of the data should reflect the research aim. In this case a key aim was 
to characterise the variation in use of the trigger tool between younger and older groups. 
Two other members of the research team reviewed the themes to enhance rigour.(23)  
Comparison of reflection and interview data 
Comparing themes from both the data sets enabled us to compare GP perceptions of the 
tool with actions documented in the trigger tool.  The themes from the transcripts, on 
occasion, were challenged by the themes that emerged from the reflective comments. 
 
Results 
Interview data 
The purposive sample of eight practitioners included six GPs, one pharmacist and one 
practice manager. Including the views of a range of staff was important as processes for 
running the trigger tools vary across practices. Figure 2 shows the analytic framework (17) of 
themes and subthemes. 
 
 
 
 
 
 
 
Figure 2.  Interview themes and subthemes  
  
 
Theme 1: Getting started 
Firstly, the existing trust and working relationship with the Clinical Effectiveness Group (11) 
was seen to be important in getting started with trigger tool implementation. One GP stated 
the reason for installing the trigger tool was because of the value that previous CEG 
interventions had brought 
 “So, I’m more likely to try things out actually because I know there will be some value 
 or some use to it.  It’s not going to be just an aimless tick boxing exercise, there is a 
 point to it.” (GP) 
The analysis highlighted key practice elements needed to gain maximum benefit from using 
the trigger tool. Good practice organisation, a strong core administrative team and an 
existing safety culture were all cited as reasons for getting started. 
“ ..it works because we’ve got a great administrator called [Name], and she just owns 
the process….I think it’s actually, what appealed to [Name] is that she was quite 
compelled by the safety element of it….” (GP) 
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Getting Started
A further driver for implementation and sustainability was the short time it took to review 
each patient, with one GP saying that the whole process was streamlined and took just 2-3 
minutes per patient. Another said of current systems 
“it (can) involve me writing a form, picking up the phone, sending a message, it’s just 
it takes time. …if you can be of free of the administrative stuff I’ll make better clinical 
decisions….” (GP) 
One interviewee alluded to barriers affecting the use of the trigger tool, with uncertainty on 
whether a patient’s eGFR had been adjusted for the Black ethnicity correction. 
Theme 2: Trigger tool for safety 
Many interviewees cited the importance of the trigger tool acting as a safety net, even 
though practice systems (such as EMIS) have the capability to run graphs of kidney function 
over time to identity progressive kidney disease.  
 “We look at this tool so if there are patients who are likely to decline there is a safety 
 net.” (GP) 
and  
 “I mean clinical governance wise it's, it feels safe, I'm looking for clinical safety and 
 this gives us clinical safety in this little, particular area.” (GP) 
A change of practice, such as prompting the clinician to undertake a medication review, was 
evident, with the pharmacist saying that patients were called up for repeat blood tests 
following review of the trigger, amendments to medications such as metformin, as well as 
checking the patient is coded for CKD. Another important issue raised was a possible change 
to proactive patient management rather than relying on reactive care. The trigger tool has 
prompted this interviewee to:  
 “…let’s go and have a look at your notes and see what’s happening.  That’s really
 different to how we practice, which tends to be quite on the back foot, so you’re 
 reacting to something all the time.  And actually, to do something pro-active and 
 really use the record….”  (GP) 
 
Theme 3: Trigger tool for learning 
Practice staff reflected on an improved degree of confidence in managing CKD: 
 “About the importance of a healthy kidney and how to do it.  And that, I think that 
was, for me that was the greatest learning experience really and it’s like it’s diabetes 
and blood pressure and medication and when we need to refer.” (GP) 
and felt more at ease in referring/ requesting tests:  
“Absolutely.  So, I think I’m a lot more confident in requesting things in terms of 
investigations now.” (GP) 
Some GPs recognised the change in practice as a result of using the tool, with more 
attention to the patients’ eGFR trajectory:  
“...they’re not looking at eGFR as an isolated thing anymore, they’re very much, when 
you look at your blood test results you’re just looking at trajectories all the time.” 
(GP) 
 
Some interviewees cited the usefulness of the trigger tool to reflect on clinical practice 
 “…if there was anything so for example that was prescribed that could have caused 
it?  Or whether there was any intercurrent illness? “(Pharmacist) 
The impact of the trigger tool on practice team learning was also evident with interviewees 
describing ways in which colleagues had acted on recommendations from the CKD lead-
clinician:  
“So I think this is, this made, I think a big difference for us…  if you send a clinician a 
practice note to remind them of a drop in the eGFR, then to see a few weeks later 
that they actually had acted upon it...” (GP)   
The impact on working relationships and shared patient care were evident if the patients 
highlighted by the trigger tools were then discussed in a practice team meeting: 
“So I think that’s a great benefit because you end up talking about it in the clinical 
meetings and I think, I think it’s stirred up or created greater awareness, I think, 
amongst us.”  (GP) 
Trigger tool reflective data 
Reflective data were collated from 1921 completed trigger tools from two CCGs over a two-
year period (January 2016 to December 2017). Generally, these free-text data varied from 
being very brief to quite detailed, with the latter providing more potential for identifying 
emerging themes. In a sample of 1000 records from 79 practices, 92% of reflections were 
completed, 64% resulted in actions and 10% resulted in referrals to the virtual CKD 
secondary care clinic.  Table 1 shows the free-text data categorised by age group and 
grouped by whether the drop in eGFR is >15 or >25ml/min.  
 
Table 1. Summary of clinical activity and referrals recorded in free-text reflections over 2 
years in 79 practices.  
 
 Younger (<60 years)  Older (>80 years) 
All cases     
N 1016 905 
Referred N (%) 81 (8) 70 (8) 
Action (%) (review, 
retest, medication 
review)  696 (69) 567 (63) 
    
    
eGFR drop >15     
N (%) 542 (53) 362 (40) 
Referred N (%) 35 (6) 27 (7) 
    
    
eGFR drop >25   
N (%) 173 (17) 91 (10) 
Referred N (%) 11 (6) 3 (3) 
   
 
 
Categorisation of the reflection data, by age and referral, enabled the observation of 
potential variations in clinical management of patients, including the comparison of younger 
versus older patients. Both age groups had a referral rate of 8% overall. Over 50% of cases 
had a fall exceeding 10mls/min/1.73m2, however even with eGFR drops of >15 and 
>25mls/min/1.73m2 the referral rates remained similar.  Referral rates were also similar 
across age groups regardless of the size of fall in eGFR.  
 
In the Younger- Referred group, reflection data describe cases where referral was 
undertaken for safety: 
 ‘immediate repeat has been requested but will refer for safety’  and 
 ‘SLE nephritis, need to keep renal informed, may just be normal fluctuation, recent MI.’  
In this group, the most common reflections were about the need for blood pressure and 
blood sugar control (10/81 cases).   
In the Younger-Not Referred group there is an emphasis on repeat tests and monitoring, this 
was often presented as a reason for deferring a decision to refer. Some data describe 
improvements in eGFR on retesting, suggesting unknown, but transient, reasons for the 
drop in eGFR:  
‘Under review, may refer at later stage if persistent problem’.  
 ‘repeat blood test showed improvement in renal function’, 
 In this group, the most common reflections were about control of risk factors, and the fall 
in eGFR being the first ever drop, with expectation of recovery.   
The Older-Referred group highlights the complexity of managing patients with multi-
morbidity: 
 ‘recent significant drop, in line with other health deterioration…advice has been sought from 
nephrologists to help with further decisions’  and  
‘Fluctuating eGFR on downward trajectory, likely related to age and diabetes and diuretics 
being used for CCF.’  
The most common reflections in this group concerned age appropriate eGFR decline (7/70 
cases).   
The Older-Not Referred group, in common with the younger group, had an emphasis on 
repeat tests and monitoring: 
 ‘Patient elderly and eGFR repeated and rose again to 66. BP diastolic readings are low, so 
perfusion may be low. Will repeat again in 1/12 and if remains low then will refer.’  
Other reflections recorded a review of the eGFR trajectory over time: 
‘Fluctuating eGFR – current value same as 2011. Over 5 years has been as low as 41 and 63 
highest value. Referral unlikely helpful at this stage – decision for continued monitoring.’ 
These recorded actions reflect some of the themes from the interviews, in particular the 
sub-themes of monitoring in the Not Referred groups and the trigger tool as safety net in 
the Referred groups.   
 
Discussion 
Main findings 
Evidence from the interviews indicate that overall, practices welcomed the falling eGFR 
trigger tool.  For most practices it was rapidly embedded into workflow with resulting 
sustainability. Over the three years of the project >90% of the tools have had a free text 
comment. This is in contrast with other quality improvement interventions that often report 
challenges in sustaining longer-term change. (24) This study also identified the importance 
of practice organisation and motivated administrative support to enable rapid uptake, and 
of trust in the clinical value of the intervention. 
Our study has utilised two types of data (practitioner perspectives and practitioner 
actions/reflections on the trigger tool) which has enabled a richer understanding of how the 
trigger tools are used in practice. Reflection data highlighted cases of poorly controlled 
diabetes/hypertension for the Young Referred group, while many older referrals reflected 
gaining specialist support for a known plan. Generally, the Not Referred groups showed that 
GPs had implemented a clinical management plan involving repeat tests and monitoring. 
The free text data stratified by age challenged the research group’s expectation that 
younger cases would have higher referral rates, driven by an established higher level of risk 
for progression. (19) In fact referral rates for each cohort were similar, suggesting an equal 
distribution of concern for younger and older patients.  
 
Comparison with existing literature 
Few studies have examined the use of e-alerts based on routine primary care records to 
detect progressive kidney disease. The most comparable work is that of Kennedy et al (25), 
which describes a population surveillance system using laboratory data to enable early 
detection of patients at high risk of progressive CKD, with eGFR graph review carried out by 
laboratory staff. This intervention has seen evidence of spread and sustainability since 2010 
(26), with 12 sites running the intervention for more than one year, 8 for more than two 
years and 2 sites running for more than three years.  A study by Holmes et al  on the use of 
an e-alerts for acute kidney injury (AKI) in Welsh primary care, (27)  suggests that outcomes 
were better for patients with AKI identified in primary care settings if the alert resulted in a 
repeated measure of kidney function within the next seven days.  
 
Jeffries et al (28) explored the implementation of a ‘socio-technological’ intervention, in the 
form of electronic medicines optimisation system (EMOS) run by a CCG. Their study, like 
ours, acknowledged that practices need a strong core administration to adopt such safety 
tools. Their finding that practice engagement was compromised by concerns about access to 
data and perceptions of ownership of the system relate to the importance of local context 
described in our study. Developing the trust required for busy practices to engage with an 
innovation, and allow data sharing, requires QI organisations embedded in the 
infrastructure of local practice. 
Sustaining a quality improvement intervention is often a challenge for health services. 
Convincing clinicians and managers that there is a problem, and getting data collection and 
monitoring systems right, are critical to success.(29)  The trigger tool appears to be well-
received by GPs because current systems do not alert practitioners to falling eGFR 
trajectories, and the tool is quick and easy to use. As one interviewee commented “you’ve 
got to make the right thing easy to do.” 
Strengths and limitations 
A strength of this project is that the tools were used in all practices across three east London 
CCGs without any selection. The interviews included administrative staff as well as GPs 
which provided a balanced view of how the tools were used in practices. 
The large number of free text reflections allowed us to gain a real impression of how 
patients were managed. The reflection data provided additional evidence to support the 
‘Trigger tool as a learning tool’ and ‘Patient safety’ themes derived from the interviews. The 
reflection data also challenged the research group’s preconception that younger patients 
would be referred more frequently than older patients, in view of their greater risk of CKD 
progression (19).   
The free text reflection data was anonymised, hence it was not possible to track the clinical 
impact of the trigger tools on individual clinical outcomes. 
 
Implications for practice and further research  
Practice use of the falling eGFR trigger tool supports the patient safety agenda, as the tool 
highlights the trajectories of kidney function rather than the latest result which is often 
viewed in isolation. (25)  In addition, the study identifies much ‘hidden care’ undertaken by 
GPs which may have an impact on CKD progression. This is in contrast to reports of 
“tensions around the management of people with CKD”, and uncertainty around the 
benefits of disclosure of a CKD diagnosis (30), which suggest there is continuing ambivalence 
in the identification and management of people with early CKD. 
Trigger tools have additional benefits beyond safety. Themes from the interviews identified 
practice team learning, including upskilling of clinicians in CKD management, examples of 
reflective practice and promotion of team working. Another UK study (31) suggested that 
trigger tools can enable care teams to refocus their learning and improvement efforts, 
whilst a previous study in east London (13) found that trigger tools engaged clinicians in 
ongoing reflective work around clinical safety.     
 
Conclusion 
Our study has shown that a falling eGFR trigger tool can be used effectively across 
unselected practices in an inner urban area. The tool was seen as easy to use, and 
supported the patient safety initiative, as well as promoting a team learning approach to 
CKD. Such tools are an effective use of data within the electronic health record and have 
applications in other domains of practice.  
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Appendix 1: Interview questions 
Question 
category 
Questions and prompts 
Structure How did you get started with the trigger tools? 
Prompt: did you discuss the worth of running the searches, whose idea was it? 
 
How are trigger tools organised in your practice? Who is responsible for them? 
Prompt: Are there any alerts, are they regular, do you prioritise the task or is it 
something at the bottom of your list? 
Process How do you work with the trigger tool? 
Prompts - how long does it take, how often are you running the tool?  
 
Are there any drivers/barriers to using the trigger tools? 
Prompts – is it sustainable? 
Outcome Are there any benefits in using the tool?  
Prompts – any specific cases where it has benefitted patients, any personal benefits, 
any use in other specialities?  Is the reflection part useful?  
 
Appendix 2 
Examples of reflective data extracted from the falling eGFR trigger tool. 
 
Age 
group Age 
Latest 
eGFR 
Previous 
eGFR  Referred? Reflection Theme 
Younger 
60 59 75 Yes He has been referred to the 
community CKD clinic. His BP is well 
controlled on medications.  
Control of risk 
factors 
  
51 47 79 No fit healthy relatively young pt, ?why 
had low eGFR on one occ, repeat is 
normal   
Repeat as one 
eGFR 
 
57 53 73 No DM - good control, good BP on ACEi 
- plan is to rpt GFR end june check 
trajectory  
Monitor 
Older 
85 54 75 Yes Will refer/drop unaccounted for Drop 
unaccounted 
for   
  
84 55 73 Yes eGFR gone down despite well 
controlled diabetes and BP. Patient 
is now 84years old, should we be 
doing more?   
Advice sought 
  
86 52 73 No pt is palliative care, bloods were 
done routinely by comm matron but 
not clinically indicated and 
therefore decision was made not for 
further action- end stage dementia.   
End of life  
 
 
 
 
